BSE Live
Oct 24, 16:01Prev. Close
121.95
Open Price
121.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 24, 15:59Prev. Close
121.61
Open Price
120.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
113.30 (7)
| Cash Flow of Brooks Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 3.23 | 1.55 | -8.19 | 0.67 | -8.44 | |
| Net CashFlow From Operating Activities | 2.52 | -9.68 | 0.56 | 3.12 | -0.90 | |
| Net Cash Used In Investing Activities | -45.97 | 0.18 | -0.40 | 1.12 | -0.75 | |
| Net Cash Used From Financing Activities | 43.36 | 9.60 | -0.22 | -4.22 | 1.31 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.08 | 0.10 | -0.06 | 0.02 | -0.33 | |
| Cash And Cash Equivalents Begin of Year | 0.13 | 0.02 | 0.08 | 0.06 | 0.40 | |
| Cash And Cash Equivalents End Of Year | 0.04 | 0.13 | 0.02 | 0.08 | 0.06 |
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.03.2025
Brooks Labs Consolidated December 2024 Net Sales at Rs 38.45 crore, up 76.8% Y-o-Y
18.11.2024
Brooks Labs Standalone September 2024 Net Sales at Rs 20.79 crore, down 14.49% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.03.2025
Brooks Labs Consolidated December 2024 Net Sales at Rs 38.45 crore, up 76.8% Y-o-Y
18.11.2024
Brooks Labs Standalone September 2024 Net Sales at Rs 20.79 crore, down 14.49% Y-o-Y